1. Home
  2. YDKG vs EVGN Comparison

YDKG vs EVGN Comparison

Compare YDKG & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDKG

Yueda Digital Holding Class A Ordinary Share

HOLD

Current Price

$1.08

Market Cap

5.3M

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$0.54

Market Cap

5.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDKG
EVGN
Founded
2005
1999
Country
China
Israel
Employees
18
N/A
Industry
Advertising
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
YDKG
EVGN
Price
$1.08
$0.54
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
24.9K
806.7K
Earning Date
05-12-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.37
52 Week High
$3.90
$1.50

Technical Indicators

Market Signals
Indicator
YDKG
EVGN
Relative Strength Index (RSI) 63.13 44.99
Support Level $0.81 $0.37
Resistance Level $1.13 $1.23
Average True Range (ATR) 0.07 0.06
MACD 0.01 -0.00
Stochastic Oscillator 90.48 16.20

Price Performance

Historical Comparison
YDKG
EVGN

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a Web3 and digital company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: